---
title: "Citius Pharma (CTXR.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/CTXR.US/norm.md"
symbol: "CTXR.US"
name: "Citius Pharma"
parent: "https://longbridge.com/zh-CN/quote/CTXR.US.md"
datetime: "2026-05-21T18:02:23.390Z"
locales:
  - [en](https://longbridge.com/en/quote/CTXR.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CTXR.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CTXR.US/norm.md)
---

# Citius Pharma (CTXR.US) — 财务报表

## 利润表 (USD)

| 指标 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.9500 | -0.3824 | -0.4628 | -0.7986 | -1.27 |
| ROE | -120.03% | -44.58% | -48.02% | -55.93% | -69.27% |
| 营业收入 | 1.67M | 3.94M | - | - | - |
| 净利润 | -21.23M | -8.22M | -7.96M | -8.79M | -10.92M |
| 营业利润 | -30.47M | -8.45M | -8.44M | -8.79M | -11.26M |
| 毛利率 | 80.27% | 79.99% | - | - | - |
| 净利率 | -1273.39% | -208.43% | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 132.54M | 140.39M | 130.94M | 127.68M | 121.48M |
| 权益乘数 | 1.92 | 1.50 | 1.69 | 1.89 | 1.91 |
| 每股净资产 | 2.75 | 3.57 | 3.74 | 4.49 | 6.92 |
| 资产周转率 | 0.0442 | 0.0302 | - | - | - |
| 现金及短投 | 4.59M | 7.72M | 4.25M | 6.09M | 26410.00 |
| 存货与应收 | 22.66M | 22.64M | 22.29M | 17.21M | 15.34M |
| 长期投资 | 794518.00 | 835177.00 | 818694.00 | 880732.00 | 922099.00 |
| 净债务 | -3.78M | -5.89M | -2.44M | -4.21M | 905385.00 |

## 现金流量表 (USD)

| 指标 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -1.30M | -13.01M | -11.88M | -5.41M | -4.54M |
| 投资现金流 | -600000.00 | -4.40M | -5.75M | - | - |
| 融资现金流 | -1.23M | 20.88M | 15.79M | 11.47M | 3.47M |
| 自由现金流 | 6.82M | -17.97M | -20.11M | -1.91M | -270664.00 |
| 现金流充裕率 | -130.00% | - | - | -1802.21% | - |
| 举债与偿债 | - | - | 0.0000 | 1.30M | - |
| 资本支出 | - | - | - | - | - |